Oxford Gene Technology Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Oxford Gene Technology Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011201
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Gene Technology Ltd (OGT) is a provider of genetics research solutions. The company’s products include fish probes, custom cancer panels, custom AML panel, custom breast cancer panel, custom FH panel, core MPN panel, ovarian cancer panel, myeloid panel, solid tumour panel, FFPE DNA repair mix and NGS library preperation kit. It provides medical research exome array, austim research array and epilepsy research array. OGT offers services such as targeted sequencing services, sureseq solid tumour panel sequencing service, RNA-seq service, miRNA analysis, gene expression analysis, cytosure services and aCGH for CNV analysis. The company’s products find application in cancer research, clinical genetics research, cytogenetics research, molecular genetics research, and pre-implantation genetic screening. OGT is headquartered in Begbroke, the UK.

Oxford Gene Technology Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Gene Technology Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Gene Technology Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Oxford Gene Technology Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Institute of Cancer Research Enters Into Licensing Agreement With Oxford Gene Technology For Prostate Cancer 10
Oxford Gene Technology Enters Into Licensing Agreement With Oslo University Hospital And University of Oslo 11
Oxford Gene Enters Co-Development Agreement With Emory Genetics For New CGH Arrays 12
Oxford Gene Technology Enters Into Co-Development Agreement With Abcodia 13
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 14
Oxford Gene Technology Enters Into Licensing Agreement With Cancer Cytogenomics Microarray Consortium 15
Asset Transactions 16
Sengenics Acquires Protein Array Technology Platform from Oxford Gene Technology 16
Acquisition 17
Oxford Gene Technology Acquires Cytocell, Genomic Medicine Company 17
Oxford Gene Technology Ltd – Key Competitors 18
Oxford Gene Technology Ltd – Key Employees 19
Oxford Gene Technology Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Nov 22, 2016: OGT announces commercial and financial highlights for FY 2016 21
Product News 22
Apr 25, 2017: OGT’s expanded NGS cancer panels enable sequencing of difficult genes 22
Dec 15, 2016: OGT Expands Cytocell Sarcoma FISH Probe Range 23
Dec 08, 2016: OGT releases targeted NGS panel to study SNV and CNV in FH 24
Oct 11, 2016: Customer Input Drives Expansion of OGT’s Cytocell Aquarius Haematology FISH Probe Range 25
Sep 27, 2016: OGT Simplifies Detection of Important Cancer Gene Variants 26
Jun 21, 2016: OGT launches 9 new Cytocell Aquarius FISH probes 27
Mar 16, 2016: OGT expands leading constitutional array range 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Oxford Gene Technology Ltd, Medical Equipment, Key Facts 2
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Oxford Gene Technology Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Oxford Gene Technology Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Oxford Gene Technology Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Oxford Gene Technology Ltd, Deals By Market, 2011 to YTD 2017 8
Oxford Gene Technology Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Institute of Cancer Research Enters Into Licensing Agreement With Oxford Gene Technology For Prostate Cancer 10
Oxford Gene Technology Enters Into Licensing Agreement With Oslo University Hospital And University of Oslo 11
Oxford Gene Enters Co-Development Agreement With Emory Genetics For New CGH Arrays 12
Oxford Gene Technology Enters Into Co-Development Agreement With Abcodia 13
Oxford Gene Enters into Licensing Agreement with Wellcome Trust Sanger Institute 14
Oxford Gene Technology Enters Into Licensing Agreement With Cancer Cytogenomics Microarray Consortium 15
Sengenics Acquires Protein Array Technology Platform from Oxford Gene Technology 16
Oxford Gene Technology Acquires Cytocell, Genomic Medicine Company 17
Oxford Gene Technology Ltd, Key Competitors 18
Oxford Gene Technology Ltd, Key Employees 19
Oxford Gene Technology Ltd, Subsidiaries 20

★海外企業調査レポート[Oxford Gene Technology Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hosken Consolidated Investments Ltd (HCI):企業の財務・戦略的SWOT分析
    Hosken Consolidated Investments Ltd (HCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Universal Music Group:企業の戦略的SWOT分析
    Universal Music Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Ei Towers SpA:企業の戦略・SWOT・財務分析
    Ei Towers SpA - Strategy, SWOT and Corporate Finance Report Summary Ei Towers SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Petrolia SE (PDR):企業の財務・戦略的SWOT分析
    Summary Petrolia SE (Petrolia), formerly Petrolia E&P Holdings SE is an oil and gas company that offers well technology solutions. The company operates through two segments such as exploration and production (E&P), and oil service segments. Its E&P’s segment seeks to maximise field potential through …
  • ARCA biopharma Inc (ABIO):医療機器:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Legal & General Group Plc:戦略・SWOT・企業財務分析
    Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report Summary Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The Advisory Board Company (ABCO):企業の財務・戦略的SWOT分析
    The Advisory Board Company (ABCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Melia Hotels International SA:企業の戦略・SWOT・財務情報
    Melia Hotels International SA - Strategy, SWOT and Corporate Finance Report Summary Melia Hotels International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Glaukos Corp (GKOS):企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Intralytix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Intralytix Inc (Intralytix) is a biotechnology company that develops, produces and markets bacteriophage based products to control bacterial pathogens. The company offers food safety products, pet food safety products and pre-harvest interventions. Its food safety products include listshield …
  • Canon Medical Systems Corp:企業の戦略的SWOT分析
    Canon Medical Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Jeil Pharmaceutical Co Ltd (002620):企業の財務・戦略的SWOT分析
    Jeil Pharmaceutical Co Ltd (002620) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Triple-S Management Corp (GTS):企業の財務・戦略的SWOT分析
    Triple-S Management Corp (GTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Harley-Davidson, Inc.:企業の戦略・SWOT・財務情報
    Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report Summary Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Victek Co., Ltd.:企業の戦略・SWOT・財務分析
    Victek Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Victek Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Aperam SA:企業の戦略・SWOT・財務情報
    Aperam SA - Strategy, SWOT and Corporate Finance Report Summary Aperam SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • The US Oncology Network:企業の戦略的SWOT分析
    The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), a subsidiary of Aarti Group of Industries is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and special …
  • Sun A. Kaken Co. Ltd.:企業の戦略・SWOT・財務情報
    Sun A. Kaken Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sun A. Kaken Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆